Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1981-02-26
1983-11-01
Waltz, Thomas A.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
424317, 424324, 424263, 560 45, 562433, 564 86, 564175, 546305, A61K 3124, A61K 3119, C07C 6352, C07C 6976
Patent
active
044130112
ABSTRACT:
New substituted 2,2-dimethyl-5-phenoxypentanoic acid benzamides which are useful as anti-arteriosclerotic agents are disclosed. These compounds elevate the high density lipoprotein fraction of cholesterol, and also lower the low density lipoprotein fraction of cholesterol.
REFERENCES:
patent: 3551478 (1970-12-01), Schmitt et al.
patent: 3985790 (1976-10-01), Metz et al.
patent: 4260816 (1981-04-01), Albright et al.
Holmes Ann
Sircar Ila
Janssen Jerry F.
Waltz Thomas A.
Warner-Lambert & Company
LandOfFree
Substituted 2,2-dimethyl-5-phenoxypentanoic acid benzamides as a does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted 2,2-dimethyl-5-phenoxypentanoic acid benzamides as a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted 2,2-dimethyl-5-phenoxypentanoic acid benzamides as a will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2168749